Loyal
About Loyal
Loyal is a clinical-stage veterinary medicine company focused on extending healthy lifespans for dogs. The company develops therapies and conducts studies to address age-related diseases with preventive care approaches, aiming to help dogs live longer, healthier lives. It operates in the United States with ongoing clinical trials and partnerships to advance canine longevity. The organization emphasizes science-driven veterinary care and aging research to support dog owners and veterinary professionals.
Recent News
Loyal Raises $100 Million: Dog Longevity Drugs Targeting IGF-1 and PPAR Pathways
Loyal Raises $100 Million: Dog Longevity Drugs Targeting IGF-1 and PPAR Pathways
Your Next Dog May Live Longer
Loyal's Canine Longevity Pill Nears Market After FDA Deems Likely Effective
Loyal's Longevity Pill Shows One‑Year Lifespan Boost in 1,300‑Dog Trial